Pfizer to double vaccine roll out as Biden assures shots for all by July

Pfizer CEO Albert Bourla said the company expects to double its rollout of coronavirus vaccines to 10 million a week over the next two weeks as Biden pledged enough supply of doses by July

Pfizer
ANI US
2 min read Last Updated : Feb 20 2021 | 8:24 AM IST

Pfizer CEO Albert Bourla said the company expects to double its rollout of coronavirus vaccines to 10 million a week over the next two weeks as US President Joe Biden pledged enough supply of doses to immunize all Americans by July.

"In [the] next couple weeks, supply will increase from 5 million to 10 million doses per week," Bourla told a briefing at drug maker's plant in Kalamazoo, Michigan, which Biden toured on Friday.

Biden, addressing media and other visitors to the plant, said his administration was on track with its goal to vaccinate 100 million Americans in its first 100 days, and also distribute 600 million doses by July 29.

"The United States will have enough vaccine for the public by end of July," Biden said.

Earlier on Friday, US Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky said the United States has vaccinated 41 million Americans since December 14, and save for a few who experienced some common after-effects, there had been no reason for concern.

White House coronavirus response adviser Andy Slavitt said the United States was experiencing a backlog in the delivery of 6 million coronavirus vaccines due to bad weather this week.

"The 6 million doses represent about three days of delayed shipping. But 1.4 million doses are already in transit. We anticipate all the backlogged doses will be delivered next week, with most being delivered within the next several days. We will be able to catch up," Slavitt added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccinePfizer

First Published: Feb 20 2021 | 7:53 AM IST

Next Story